A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
NCT03312842
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
259
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
CS1001
Sponsor
CStone Pharmaceuticals